quisqualic acid has been researched along with oxidopamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riekkinen, M; Riekkinen, P; Sirviö, J | 1 |
| Edwardson, JA; Keith, AB; Kerwin, JM; Lloyd, S; Perry, EK; Sahgal, A | 1 |
| Agid, Y; Brice, A; Duyckaerts, C; Hauw, JJ; LeMoal, M; Mayo, W; Ruberg, M; Simon, H | 1 |
| Everitt, BJ; Robbins, TW | 1 |
| Daszuta, A; Forni, C; Moukhles, H; Nieoullon, A | 1 |
| Monard, D; Nitsch, C; Scotti, AL | 1 |
1 review(s) available for quisqualic acid and oxidopamine
| Article | Year |
|---|---|
Comparative functions of the central noradrenergic, dopaminergic and cholinergic systems.
Topics: Acetylcholine; Animals; Behavior, Animal; Brain; Caudate Nucleus; Discrimination Learning; Dopamine; Electric Stimulation; Hydroxydopamines; Ibotenic Acid; Norepinephrine; Nucleus Accumbens; Oxadiazoles; Oxidopamine; Putamen; Quisqualic Acid | 1987 |
5 other study(ies) available for quisqualic acid and oxidopamine
| Article | Year |
|---|---|
Neurophysiological consequences of combined cholinergic and noradrenergic lesions.
Topics: Animals; Cerebral Cortex; Choline O-Acetyltransferase; Electrophysiology; Male; Norepinephrine; Olivary Nucleus; Oxidopamine; Quisqualic Acid; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Tacrine | 1992 |
Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: potentiation of disruption by scopolamine.
Topics: Animals; Brain Chemistry; Choline O-Acetyltransferase; Hydroxydopamines; Male; Memory; Norepinephrine; Oxidopamine; Parasympathetic Nervous System; Psychomotor Performance; Quisqualic Acid; Rats; Scopolamine; Sympathectomy, Chemical; Sympathetic Nervous System | 1990 |
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain Injuries; Choline O-Acetyltransferase; Female; Humans; Hydroxydopamines; Kinetics; Male; Neuromuscular Depolarizing Agents; Oxadiazoles; Oxidopamine; Parkinson Disease; Phencyclidine; Piperidines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine; Reference Values; Substantia Nigra; Temporal Lobe | 1990 |
Regulation of dopamine levels in intrastriatal grafts of fetal mesencephalic cell suspension: an in vivo voltammetric approach.
Topics: 2-Amino-5-phosphonovalerate; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Benzazepines; Brain Tissue Transplantation; Cerebral Ventricles; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine D2 Receptor Antagonists; Female; Fetal Tissue Transplantation; Glutamic Acid; Injections, Intraventricular; Kinetics; Mesencephalon; N-Methylaspartate; Oxidopamine; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride; Time Factors; Transplantation, Heterotopic | 1994 |
Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra.
Topics: Amyloid beta-Protein Precursor; Animals; Carrier Proteins; Glial Fibrillary Acidic Protein; Ibotenic Acid; Immunohistochemistry; Male; N-Methylaspartate; Nerve Degeneration; Oxidopamine; Protease Nexins; Putamen; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Glutamate; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 1994 |